Emergent Biosolutions (EBS) Reports Q2 EPS of 13c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.59 +2.23%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Emergent Biosolutions (NYSE: EBS) reported Q2 EPS of $0.13, may not compare to the analyst estimate of $0.32. Revenue for the quarter came in at $110.3 million versus the consensus estimate of $109.25 million.
For earnings history and earnings-related data on Emergent Biosolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
- Emergent BioSolutions (EBS) PT Lowered to $10 at H.C. Wainwright
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
